Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

News > All

Total search results: 9799 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 56 57 58 ... 96 97 98  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Acino Holding AG. (10/2/13). "Press Release: Avista Capital Partners and Nordic Capital to Launch a Joint Public Tencer Offer to Acquire Acino. Offer Price of CHF 115.00 Represents a 33% Premium to the Closing Share Price on October 1, 2013". Aesch. 2013-10-02
MorphoSys AG. (10/2/13). "Press Release: MorphoSys Collaborator to Start Pivotal Study with Bimagrumab. MorphoSys to Receive Clinical Milestone Payment". 2013-10-02
BASF SE. (10/2/13). "Press Release: BASF Commences Tender Offer to Verenium’s Shareholders. Offer Period from October 2 to October 31, 2013 – Cash Offer US$4.00 per Share". Ludwigshafen. 2013-10-02
BASF SE. (10/2/13). "Press Release: BASF Raises 2020 Sales Target for Its Crop Protection Division to €8 Billion. €1.8 Billion in Investments between 2013 and 2017 to Meet Growing Market Demand". Limburgerhof. 2013-10-02
Zivak Technologies. (10/2/13). "Press Release: ZinMass Clinical LC-MS/MS Analyzer Will Be Exhibited at Medica 2013". 2013-10-02
Epigenomics AG. (10/2/13). "Press Release: Epigenomics Signs Joint Commercialization Agreement for Epi proColon in North America with Polymedco". Berlin. 2013-10-02
Bremen MS Seminar. (10/1/13). "Press Release: Bremen Mass Spectrometry Seminar Launches. First Talk by Prof. Pieter Dorrestein from the University of California – San Diego on 16th October". Bremen. 2013-10-01
Omnilab-Laborzentrum GmbH & Co. KG. (10/1/13). "Pressemitteilung: Omnilab expandiert national. Omnilab-Laborzentrum GmbH & Co. KG erweitert und bündelt Vertriebsstrukturen". 2013-10-01
EffRx Pharmaceuticals S.A.. (10/1/13). "Press Release: EffRx Receives Prestigious EUR 5.9 Million FP7 Research Grant for the Development of EX404 for PolyCystic Ovary Syndrome (PCOS) in Paediatric Populations". Freienbach. 2013-10-01
Definiens AG. (10/1/13). "Press Release: Personalized Medicine Roadmap. Definiens Releases Five Steps to Utilize Data Mining with Image Analysis". Munich & Carlsbad, CA. 2013-10-01
Amgen Inc.. (10/1/13). "Press Release: Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer. Acquisition Expected to Close Today – Deal Valued at $9.7 Billion". Thousand Oaks, CA. 2013-10-01
Activiomics Ltd.. (9/30/13). "Press Release: Activiomics Extends Capability to Clinical Biomarker Discovery and Appoints CEO". London. 2013-09-30
Dualsystems Biotech AG. (9/30/13). "Press Release: Dualsystems Biotech Closes Series C Financing Round". 2013-09-30
Evotec AG. (9/30/13). "Press Release: Evotec Receives Clinical Milestone as Part of Its Discovery Alliance with Boehringer Ingelheim". Hamburg. 2013-09-30
Analytik Jena AG. (9/30/13). "Pressemitteilung: Analytik Jena AG verlängert Verträge von Vorstandsvorsitzendem Klaus Berka und Finanzvorstand Stefan Döhmen. Gründer und Vorstand Jens Adomat verlässt das Unternehmen auf eigenen Wunsch". Jena. 2013-09-30
Ardian. (9/30/13). "Press Release: Axa Private Equity Becomes Ardian. A New Chapter Begins as an Independent Private Investment Company". Paris. 2013-09-30
Bayer AG. (9/30/13). "Press Release: Olivier Brandicourt Appointed as New CEO of Bayer HealthCare". Leverkusen. 2013-09-30
Isarna Therapeutics GmbH. (9/30/13). "Press Release: Antisense Pharma Changes Name to Isarna Therapeutics". Munich & Zurich. 2013-09-30
Bayer AG. (9/30/13). "Press Release: Bayer Submits Nexavar (sorafenib) for Marketing Authorization in Thyroid Cancer in Japan [Not intended for U.S. and UK Media]". Berlin. 2013-09-30
Mologen AG. (9/30/13). "Press Release: Final Analysis Confirmed Preliminary Results of Renal Cancer Vaccine MGN1601". 2013-09-30
Basilea Pharmaceutica Ltd.. (9/30/13). "Press Release: Basilea Reports Positive Topline Phase 3 Results for Antifungal Isavuconazole". Basel. 2013-09-30
Merck KGaA. (9/28/13). "Press Release: Merck’s Erbitux Significantly Extends Survival by 7.5 Months in mCRC RAS Wild-type Patients when Compared with Bevacizumab. New Analysis of FIRE-3 AIO Study". Darmstadt & Amsterdam. 2013-09-28
Biognosys AG. (9/27/13). "Press Release: New MRM Panel for Dried Blood Spot Samples". 2013-09-27
Endress+Hauser AG. (9/27/13). "Press Release: Endress+Hauser Prepares Offer for Analytik Jena. Swiss Measurement Technology Specialist Gains Control". 2013-09-27
M+W Group. (9/27/13). "Press Release: M+W Group Hands Over Most Advanced Research Laboratory to Nestlé". 2013-09-27
Glycotope GmbH. (9/27/13). "Press Release: Glycotope Presents Phase I Results of Novel Glycooptimized Monoclonal anti-TA-MUC1 Antibody PankoMAb-GEX at European Cancer Congress". Berlin. 2013-09-27
Ablynx N.V.. (9/26/13). "Press Release: Ablynx and Merck Serono further Strengthen Their Collaboration on Co-discovery and Co-development of Nanobodies. Creation of Dedicated Discovery Unit at Ablynx". Ghent. 2013-09-26
Berthold Technologies GmbH & Co. KG. (9/26/13). "Press Release: Berthold Technologies Launches Mithras2 Multi-technology Microplate Reader with Monochromators". Bad Wildbad. 2013-09-26
4SC AG. (9/26/13). "Press Release: 4SC Discovery and Panoptes Pharma Sign Patent Transfer Agreement for Novel Compound to Treat Severe Eye Diseases". Planegg-Martinsried & Vienna. 2013-09-26
Boehringer Ingelheim. (9/26/13). "Press Release: Boehringer Ingelheim Significantly Expands Its Production Footprint in China. Inauguration Ceremony for Zhangjiang Plant Expansion in Shanghai – Investment of 70 Million Euro". Shanghai & Ingelheim. 2013-09-26
Merck KGaA. (9/26/13). "Press Release: Merck Announces Further Management Changes to Drive Pharmaceutical Business Growth". Darmstadt. 2013-09-26
Panoptes Pharma GmbH. (9/26/13). "Press Release: Panoptes Pharma Successfully Closed Seed-financing Round of EUR 1.2 Million. Focus on Development of Small Molecule Drugs to Treat Severe Eye Diseases". Vienna. 2013-09-26
Cell Medica Ltd.. (9/26/13). "Press Release: Cell Medica Opens a Central European Manufacturing Facility in Berlin-Buch (Germany)". London. 2013-09-26
Merck KGaA. (9/25/13). "Press Release: Merck Announces Decision to Continue the Development of Tecemotide in Stage III Non-small Cell Lung Cancer". Darmstadt. 2013-09-25
Pacific Biosciences of California, Inc.. (9/25/13). "Press Release: Pacific Biosciences Announces Agreement with Roche Diagnostics to Develop and Supply DNA Sequencing-based Products for Clinical Diagnostics". Menlo Park, CA. 2013-09-25
Indivumed GmbH. (9/25/13). "Press Release: Indivumed Sells Inostics, the Plasma-DNA Company, to Sysmex and Expands Its Clinical Research Service and Patient Diagnostics Business". Hamburg. 2013-09-25
Boehringer Ingelheim. (9/25/13). "Press Release: Giotrif (afatinib) Approved in Europe for Patients with EGFR Mutation Positive Lung Cancer [For non U.S. Media Only]". Ingelheim. 2013-09-25
Mologen AG. (9/25/13). "Press Release: Mologen AG Submitted Clinical Trial Application (IND) for MGN1703 to the FDA". 2013-09-25
Bruker Corporation. (9/24/13). "Press Release: New minispec Sample Automation System for TD-NRM Applications Delivers Increased Productivity and Efficiency". Karlsruhe. 2013-09-24
Sysmex Corporation. (9/24/13). "Press Release: Sysmex Acquiring Two Germany Based Companies to Expand Its Technology Platform Targeting Personalized Medicine and Entering New Fields of Business". 2013-09-24
Nanion Technologies GmbH. (9/24/13). "Press Release: Nanion Starts Shipping the SyncroPatch 384 Patch Engine – a Revolutionary Instrument for Giga-seal, Automated Patch Clamb-based Ion Channel Drug Screening". Munich. 2013-09-24
Evogene Ltd.. (9/24/13). "Press Release: Evogene Files Registration Statement for Proposed Initial Public Offering in the United States". Rehovot. 2013-09-24
Myelo Therapeutics GmbH. (9/23/13). "Press Release: Myelo Therapeutics GmbH Closes Financing Round for Development of Adjuvant Cancer Therapy". Berlin. 2013-09-23
Formycon AG. (9/23/13). "Press Release: Formycon AG Moves Steadily Forward with Product Pipeline, Announces Half-year Results". Munich. 2013-09-23
Analytik Jena AG. (9/20/13). "Press Release: Analytik Jena AG Successfully Completes Capital Increase". Jena. 2013-09-20
BioOutsource Ltd.. (9/20/13). "Press Release: BioOutsource Launches Comprehensive Range of Off-the-Shelf Testing Methodologies to Support Biosimilar Characterization and Comparability Testing". Boston, MA & Glasgow. 2013-09-20
BASF SE. (9/20/13). "Press Release: BASF Announces Cash Offer to Acquire Specialized Enzyme Biotechnology Company Verenium. Cash Offer US$4.00 per Share". Ludwigshafen. 2013-09-20
Actelion Ltd.. (9/19/13). "Press Release: Actelion Closes Acquisition of Privately-held Ceptaris Therapeutics Adding Valchlor to Actelion’s Product Portfolio. Valchlor Is the Only FDA-approved Topical Formulation of Mechlorethamine". Allschwil. 2013-09-19
Analytik Jena AG. (9/19/13). "Pressemitteilung: Veröffentlichung gem. § 26 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung [Endress+Hauser hält nun 22,33% Stimmrechtsanteil]". 2013-09-19
MorphoSys AG. (9/19/13). "Press Release: MorphoSys Raises EUR 84 Million in Private Placement". 2013-09-19
Exosome Diagnostics, Inc.. (9/19/13). "Press Release: Exosome Diagnostics Enters Collaboration with Lilly for Exosome Blood-based Biomarker Discovery". New York, NY. 2013-09-19
BioGenes GmbH. (9/18/13). "Press Release: BioGenes Launches Enhanced Generic HCP Assay for Early Stage Biologics Production". Berlin. 2013-09-18
MorphoSys AG. (9/18/13). "Press Release: MorphoSys to Raise Capital via a Private Placement of New Shares". 2013-09-18
Definiens AG. (9/18/13). "Press Release: Christiaan Neeleman Appointed COO of Definiens". Munich. 2013-09-18
bm-t Beteiligungsmanagement Thüringen GmbH. (9/18/13). "Press Release: Udo Werner Named New CEO of bm-t". 2013-09-18
IKFE Services GmbH. (9/18/13). "Pressemitteilung: Die neue IKFE Services GmbH. Columbia Healthcare Serivces, Inc. gründet deutsches Unternehmen in Mainz". 2013-09-18
Addex Therapeutics S.A.. (9/17/13). "Press Release: Addex Therapeutics First Half 2013 Financial Results". Geneva. 2013-09-17
Genedata AG. (9/17/13). "Press Release: Evonik and Genedata Broaden Their Collaboration with the Genedata Selector Biotechnology Data Management Platform". Basel. 2013-09-17
High-Tech Gründerfonds Management GmbH. (9/17/13). "Press Release: Microstim Successfully Raised Funds for the First Clinical Application of Their Heart Assist System". Bonn & Wismar. 2013-09-17
MorphoSys AG. (9/17/13). "Press Release: MorphoSys Receives Two Phase 2 Milestone Payments from Janssen". 2013-09-17
Sartorius AG. (9/17/13). "Press Release: Sartorius Stedim Biotech and Alfa Laval Extend Their Partnership". Göttingen. 2013-09-17
Affimed Therapeutics AG. (9/16/13). "Press Release: Affimed Therapeutics and The Leukemia & Lymphoma Society Partner to Advance AFM13 in a Phase 2 Trial for Refractory and/or Relapsed Hodgkin Lymphoma Patients". Heidelberg & Whie Plains, NY. 2013-09-16
Bruker Corporation. (9/16/13). "Press Release: Bruker Announces Second-phase Collaboration Agreement with Siscapa Assay Technologies for Further Development and Commercialization of SISCAPA-MALDI Assays". Yokohama. 2013-09-16
Bruker Corporation. (9/16/13). "Press Release: Bruker Introduces maXis HD Ultra-high Resolution QTOF at HUPO". Yokohama. 2013-09-16
Roche. (9/16/13). "Press Release: Christoph Franz Nominated to Become New Roche Chairman". Basel. 2013-09-16
Fresenius SE & Co. KGaA. (9/13/13). "Press Release: Fresenius Helios Acquires 43 Hospitals from Rhön-Klinikum AG". Bad Homburg v. d. H.. 2013-09-13
Bruker Corporation. (9/12/13). "Press Release: Bruker Announces Acquisition of Prairie Technologies". Billerica, MA. 2013-09-12
Evotec AG. (9/12/13). "Press Release: Evotec and Harvard Stem Cell Institute Form CureMN Collaboration to Advance ALS Research". Hamburg. 2013-09-12
Jacobs University Bremen. (9/12/13). "Press Release: Phytolutions and OceanLab Install First Outdoor Microalgae Plant in Chinese City of Weihai". 2013-09-12
Nanion Technologies GmbH. (9/12/13). "Press Release: Nanion Introduces New Product Family. CardioExcyte 96 for Cardiac Toxicity Profiling and Screening". Munich. 2013-09-12
Ganymed Pharmaceuticals AG. (9/11/13). "Press Release: Ganymed Pharmaceuticals Announces CE Marking for Test to Assess Claudin-18.2 Expression in Solid Tumors". Mechelen. 2013-09-11
Markes International Ltd.. (9/11/13). "Press Release: Markes International GmbH Opens in Frankfurt, Germany". 2013-09-11
Anagnostics Bioanalysis GmbH. (9/10/13). "Press Release: Anagnostics’ Inflammation Monitoring Applied by Vienna’s Wilhelmine Hospital". 2013-09-10
Bayer AG. (9/10/13). "Press Release: Personalized Oncology. Bayer and the Broad Institute Join Forces to Develop Novel Treatment Options in Cancer Therapy [Not intended for U.S. Media]". Leverkusen & Berlin. 2013-09-10
Inovio Pharmaceuticals, Inc.. (9/10/13). "Press Release: Roche and Inovio Pharmaceuticals Partner On Inovio’s Prostate and Hepatitis B Immunotherapy Products". Basel & Blue Bell, PA. 2013-09-10
Sernova Corporation. (9/10/13). "Press Release: Sernova and Medicyte to Collaborate on Cell-based Therapy to Treat Haemophilia. Novel Approach to Address Unmet Need for an Effective Therapy". London, ON & Heidelberg. 2013-09-10
Activaero GmbH. (9/9/13). "Press Release: Activaero and Chiesi Enter into Research Collaboration for Novel Drug Device Combination in Cystic Fibrosis". Gemünden/Wohra. 2013-09-09
Debiopharm S.A.. (9/9/13). "Press Release: Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm". Lausanne & Kolkata. 2013-09-09
Evolva Holding S.A.. (9/9/13). "Press Release: Cargill and Evolva Move into Pilot Scale ahead of Schedule for Fermentation-based Steviol Glycosides". Minneapolis, MN & Reinach. 2013-09-09
Genkyotex S.A.. (9/9/13). "Press Release: Genkyotex Receives FDA IND Approval for Phase II Clinical Study with First in Class NOX Inhibitor GTK137831". Geneva & Archamps. 2013-09-09
High-Tech Gründerfonds Management GmbH. (9/9/13). "Press Release: Neurodyn Inc. Acquires Memogain for Dementia in Alzheimer’s Disease". Bonn & Mainz & Charlottetown. 2013-09-09
Paion AG. (9/9/13). "Press Release: Paion Starts Phase II Study with Remimazolam in the Indication Anaesthesia". Aachen. 2013-09-09
Bruker Corporation. (9/9/13). "Press Release: Bruker Introduces New Benchtop FT-NMR System Fourier 60". Indianapolis, IN. 2013-09-09
Novartis AG. (9/6/13). "Press Release: Novartis Announces an Exclusive Global Licensing and Research Collaboration with Regenerex, Leveraging a Novel Cell Platform to Broaden Presence in the Cell Therapy Space". Basel. 2013-09-06
Scienion AG. (9/6/13). "Press Release: MicroAcqua – a 12 Party Consortium Drives the Development of a Microarray for a Rapid, Inexpensive and Effienct Testing for Waterborne Pathogens". Dortmund & Berlin. 2013-09-06
Taros Chemicals GmbH & Co. KG. (9/6/13). "Press Release: Taros Announces Appointment of New Director of Medicinal Chemistry". Dortmund. 2013-09-06
Wilex AG. (9/6/13). "Press Release: Nuclea Biotechnologies Inc. Acquires Wilex Inc. and Extends Their Cooperation with Wilex AG. Nuclea Purchased All Shares of Wilex Inc. (Oncogene Science)". Munich & Pittsfield, MA & Cambridge, MA. 2013-09-06
Enzymatics, Inc.. (9/6/13). "Press Release: Enzymatics Acquires ArcherDx and Next-Generation Diagnostic Technology. Jason Myers, Ph.D., Co-founder and Chief Executive Officer of ArcherDx, Joins Enzymatics as Chief Scientific Officer". Beverly, MA & Bould 2013-09-06
Piqur Therapeutics AG. (9/5/13). "Press Release: Piqur Successfully Closed a Third Seed Financing Round and Received Eurostars Grant". Basel. 2013-09-05
Apceth GmbH & Co. KG. (9/5/13). "Press Release: Apceth Names Dr Stefanos Theoharis Chief Business Officer". Munich. 2013-09-05
Debiopharm S.A.. (9/5/13). "Press Release: Go To Market Consulting Inc. and Debiopharm Group Collaborate to Identify Early Stage In-licensing Opportunities on the US West Coast". Lausanne & San Francisco, CA. 2013-09-05
Analytik Jena AG. (9/4/13). "Press Release: Analytik Jena AG Approves a Subscription Rights Capital Increase of up to 1.95 Million New Shares (Ad-hoc notification in accordance with Section 15 WpHG [Securities Trading Act])". Jena. 2013-09-04
Genedata AG. (9/4/13). "Press Release: Genedata Screener Global User Group Meetings Will Examine Advancements in Plate-based Screening". Basel. 2013-09-04
High-Tech Gründerfonds Management GmbH. (9/4/13). "Press Release: HTGF Invests in Novel Approach for the Treatment of Obesity and Diabetes Type II – Perora". Bonn. 2013-09-04
Roche. (9/4/13). "Press Release: Start of the TROPICAL-ACS Large Intervention Study on Multiplate-guided Anti-platelet Therapy in ACS Patients". Rotkreuz. 2013-09-04
Ventana Medical Systems, Inc.. (9/4/13). "Press Release: Ventana and EMC Join Forces to Take Digital Pathology into the World of Big Data". Tuscon, AZ. 2013-09-04
Medicyte GmbH. (9/4/13). "Press Release: Taconic and Medicyte Announce Strategic Marketing Alliance. Taconic to Distribute Medicy Human upcyte Hepatocyte Products". New York & Heidelberg. 2013-09-04
Thermo Fisher Scientific Inc.. (9/4/13). "Press Release: Thermo Fisher Scientific and Siemens Renew Partnership for Improved Detection of Sepsis Using B.R.A.H.M.S PCT Biomarker. Procalcitonin (PCT) Immunoassay Availabiltiy Is Continued on ADVIA Centaur S 2013-09-04
Apitope International N.V.. (9/3/13). "Press Release: Apitope Announces Positive Results from Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis". Bristol & Hasselt. 2013-09-03
Leukocare AG. (9/3/13). "Press Release: Leukocare Announces EUR 3.4 M Capital Increase". Munich. 2013-09-03
next pagenext page 1 2 3 ... 56 57 58 ... 96 97 98  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

» top